Nanosilver Heparin for the Treatment of Cardiovascular Disease: Nanoparticles Diseases (CVD)

Nanomedicines can increase ef¿cacy, speci¿city, tolerability and therapeutic index of corresponding drugs with a stable, non-toxic, non-thrombogenic, nonimmunogenic, non-in¿ammatory, biodegradable, avoid uptake by reticulo-endothelial system and can also applicable to various molecules such as small drugs, proteins, vaccines vaccines or nucleic acids. This new technology should allow detecting, evaluating, analyzing, and engineering biological nanostructures. This means to open wide the whole field of nanomedicine, including nanodevices for diagnostic and therapy, drug delivery systems and regenerative medicine. The implication of nanotechnology main objective is to develop innovative nanodrug delivery in vivo and less cost-effective therapies by diseases repairing and without side effects, as well as to overcome many present bionic solutions research.